Carregant...
Safety and Efficacy of a Single Dose of Anti-D (WinRho(®)) in Severe Thrombocytopenia Secondary to Dengue Virus Infection
OBJECTIVE: To evaluate the efficacy of a single intravenous (IV) dose of anti-D in severe thrombocytopenia (<20,000) due to dengue virus (DEV) infection. MATERIALS AND METHODS: An open label, investigator-initiated, randomized interventional study was conducted that included thirty dengue patient...
Guardat en:
| Publicat a: | Indian J Crit Care Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330058/ https://ncbi.nlm.nih.gov/pubmed/28250602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijccm.IJCCM_386_16 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|